Nova Total Current Liabilities vs Total Current Assets Analysis

NLH Stock  CAD 0.26  0.01  4.00%   
Nova Leap financial indicator trend analysis is infinitely more than just investigating Nova Leap Health recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nova Leap Health is a good investment. Please check the relationship between Nova Leap Total Current Liabilities and its Total Current Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nova Leap Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Total Current Assets

Total Current Liabilities vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nova Leap Health Total Current Liabilities account and Total Current Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Nova Leap's Total Current Liabilities and Total Current Assets is 0.97. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Nova Leap Health, assuming nothing else is changed. The correlation between historical values of Nova Leap's Total Current Liabilities and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Nova Leap Health are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Total Current Liabilities i.e., Nova Leap's Total Current Liabilities and Total Current Assets go up and down completely randomly.

Correlation Coefficient

0.97
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Current Liabilities

Total Current Liabilities is an item on Nova Leap balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nova Leap Health are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Nova Leap's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nova Leap Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nova Leap Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Nova Leap's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 21.18 in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses3.3M11.0M26.6M27.9M
Cost Of Revenue14.1M18.2M16.8M9.8M

Nova Leap fundamental ratios Correlations

0.880.990.24-0.370.930.790.250.911.00.690.870.820.920.850.90.990.88-0.110.880.950.780.90.810.950.73
0.880.8-0.2-0.620.950.870.490.930.870.680.980.990.970.990.950.820.98-0.060.990.90.890.650.880.940.78
0.990.80.39-0.250.880.690.110.880.990.670.790.730.860.760.841.00.79-0.110.790.930.720.920.720.910.64
0.24-0.20.390.650.02-0.26-0.690.080.260.05-0.24-0.31-0.05-0.26-0.050.35-0.24-0.08-0.240.17-0.180.47-0.240.06-0.26
-0.37-0.62-0.250.65-0.5-0.63-0.71-0.32-0.37-0.5-0.64-0.67-0.47-0.65-0.39-0.32-0.66-0.08-0.66-0.37-0.68-0.21-0.64-0.51-0.63
0.930.950.880.02-0.50.850.370.950.920.670.940.910.970.930.930.890.93-0.180.940.980.860.770.850.990.74
0.790.870.69-0.26-0.630.850.750.750.760.530.950.850.90.860.870.710.95-0.250.890.80.770.711.00.860.95
0.250.490.11-0.69-0.710.370.750.270.210.290.620.50.480.490.460.130.62-0.050.540.280.480.180.730.40.83
0.910.930.880.08-0.320.950.750.270.90.650.90.870.960.890.960.870.88-0.080.90.960.80.70.760.940.68
1.00.870.990.26-0.370.920.760.210.90.70.860.810.910.840.880.990.86-0.10.870.950.780.90.790.950.7
0.690.680.670.05-0.50.670.530.290.650.70.650.60.650.620.640.690.620.540.640.720.90.610.560.730.58
0.870.980.79-0.24-0.640.940.950.620.90.860.650.960.970.970.950.81.0-0.130.990.890.870.680.950.940.89
0.820.990.73-0.31-0.670.910.850.50.870.810.60.960.921.00.910.760.96-0.090.980.830.850.560.860.880.74
0.920.970.86-0.05-0.470.970.90.480.960.910.650.970.920.940.990.860.96-0.160.960.960.840.750.910.970.83
0.850.990.76-0.26-0.650.930.860.490.890.840.620.971.00.940.920.790.97-0.10.990.870.860.60.870.90.75
0.90.950.84-0.05-0.390.930.870.460.960.880.640.950.910.990.920.830.93-0.090.930.930.820.710.880.930.8
0.990.821.00.35-0.320.890.710.130.870.990.690.80.760.860.790.830.8-0.10.810.930.740.920.730.920.65
0.880.980.79-0.24-0.660.930.950.620.880.860.621.00.960.960.970.930.8-0.150.990.880.850.680.950.930.88
-0.11-0.06-0.11-0.08-0.08-0.18-0.25-0.05-0.08-0.10.54-0.13-0.09-0.16-0.1-0.09-0.1-0.15-0.11-0.120.27-0.18-0.23-0.13-0.1
0.880.990.79-0.24-0.660.940.890.540.90.870.640.990.980.960.990.930.810.99-0.110.880.860.640.90.920.82
0.950.90.930.17-0.370.980.80.280.960.950.720.890.830.960.870.930.930.88-0.120.880.840.830.810.990.72
0.780.890.72-0.18-0.680.860.770.480.80.780.90.870.850.840.860.820.740.850.270.860.840.630.780.880.73
0.90.650.920.47-0.210.770.710.180.70.90.610.680.560.750.60.710.920.68-0.180.640.830.630.730.830.67
0.810.880.72-0.24-0.640.851.00.730.760.790.560.950.860.910.870.880.730.95-0.230.90.810.780.730.870.95
0.950.940.910.06-0.510.990.860.40.940.950.730.940.880.970.90.930.920.93-0.130.920.990.880.830.870.79
0.730.780.64-0.26-0.630.740.950.830.680.70.580.890.740.830.750.80.650.88-0.10.820.720.730.670.950.79
Click cells to compare fundamentals

Nova Leap Account Relationship Matchups

Nova Leap fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.1M17.5M26.8M23.9M27.5M28.9M
Total Current Liabilities4.7M4.2M6.2M4.0M4.6M3.5M
Total Stockholder Equity7.1M9.8M18.5M18.7M21.5M22.6M
Net Tangible Assets(3.2M)(1.7M)(304.1K)1.6M1.8M1.9M
Retained Earnings(3.4M)(2.1M)(357.0K)(1.2M)(1.1M)(1.1M)
Accounts Payable941.8K946.1K1.3M1.2M1.4M762.4K
Cash1.6M2.8M1.7M1.3M1.5M1.3M
Long Term Debt2.0M2.8M896.1K117.5K135.1K128.4K
Net Receivables1.7M1.4M3.9M2.4M2.8M1.5M
Good Will9.4M10.2M16.7M16.0M18.4M19.4M
Other Stockholder Equity1.6M1.6M1.8M2.1M2.5M1.6M
Total Liab7.0M7.7M8.3M5.3M6.1M4.9M
Short Long Term Debt3.5M2.7M4.0M2.4M2.7M2.4M
Total Current Assets3.5M4.3M6.0M4.0M4.6M3.0M
Short Term Debt3.6M2.9M4.3M2.7M3.1M2.5M
Intangible Assets811.3K1.3M2.1M1.1M1.3M909.5K
Common Stock9.0M10.3M17.1M19.0M21.8M22.9M
Short Long Term Debt Total5.7M6.0M6.2M4.0M4.6M4.3M
Other Current Liab93.6K19.3K127.7K57.5K51.8K103.3K
Net Debt4.1M3.2M4.5M2.7M3.1M2.9M
Non Current Assets Total10.6M13.2M20.8M20.0M23.0M12.1M
Other Assets134.3K1.3M729.1K1.3M1.5M1.6M
Cash And Short Term Investments1.6M2.8M1.7M1.3M1.5M1.4M
Common Stock Shares Outstanding48.5M60.9M66.4M77.7M89.3M57.0M
Liabilities And Stockholders Equity14.1M17.5M26.8M23.9M27.5M15.4M
Non Current Liabilities Total2.3M3.5M2.1M1.3M1.5M1.7M
Accumulated Other Comprehensive Income(120.5K)92.3K(80.6K)(1.2M)(1.1M)(1.0M)
Property Plant And Equipment Net271.3K395.3K1.3M1.5M1.7M1.8M
Net Invested Capital12.6M15.4M23.4M21.2M24.3M15.8M
Net Working Capital(1.3M)159.9K(264.5K)(10.4K)(11.9K)(12.5K)
Property Plant Equipment271.3K395.3K1.3M1.5M1.7M1.8M
Capital Stock9.0M10.3M17.1M19.0M21.8M14.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nova Stock Analysis

When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.